Navigation Links
OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Date:6/17/2010

ity.  In preclinical studies of monoclonal antibody drug candidates that target Wnt signaling, OncoMed scientists have observed broad-spectrum anti-tumor and anti-cancer stem cell activity in a number of solid tumor types.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany.  The company combines the global activities of the Animal Health, Bayer Schering Pharma, Consumer Care and Medical Care divisions.  Bayer HealthCare's aim is to discover, manufacture and market products that will improve human and animal health worldwide.  Find more information at www.bayerhealthcare.com.

About Bayer Schering Pharma

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company.  Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare.  With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide.  Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at

SOURCE OncoMed Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
2. OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
3. OncoMed Pharmaceuticals Completes Series B Financing
4. Oramed Pharmaceuticals was Chosen to Present Two Abstracts at the 70th Scientific Sessions of the American Diabetes Association in Orlando, FL, June 25-29, 2010
5. Isis Pharmaceuticals to Discuss Its Neurodegenerative Franchise in a Conference Call on Thursday, June 17
6. Anthera Pharmaceuticals Promotes Colin Hislop, M.D., to Chief Medical Officer
7. INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc.
8. OncoGenex Pharmaceuticals to Present at the 9th Annual Needham Healthcare Conference
9. Amylin Pharmaceuticals to Present at the 2010 Jefferies Global Life Sciences Conference
10. Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
11. Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014  CorMedix Inc. (NYSE MKT: CRMD), a ... products for the prevention and treatment of cardiorenal ... on July 18, 2014 from the NYSE MKT ... CorMedix plan to regain compliance with continued listing ... NYSE-MKT is continuing the Company,s listing and has ...
(Date:7/24/2014)... 1000 balances – 4 steps – One Recommendation: the ... expertly narrows down the mass of product choices to ... , First, select the working environment, then enter ... and define the accuracy – it’s really that simple. ... list to models that fit best with the customer’s ...
(Date:7/24/2014)... Brook, NJ (PRWEB) July 24, 2014 ... to manage numerous projects in the MENA region during ... to have a preferred provider agreement with DZS to ... the MENA region,” said Global VP of R&D and ... "DZS has developed excellent operational practices with a focus ...
(Date:7/23/2014)... in saving China,s endangered national treasure, the giant panda. ... reserves that have been established and three large breeding ... in the wild. , Breeding programs in conservation ... improving genetic diversity, avoid inbreeding and ultimately, introduce pandas ... programs doing so far? , In a new study ...
Breaking Biology Technology:CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2
... 2010, PRNewswire-Asia/ -- Tiens Biotech Group (USA), Inc. (the "Company" or ... , today announced financial results for the ... Revenue for the third quarter of 2010 was $10.4 million, compared ... the nine months ended September 30, 2010 was $30.0 million, compared ...
... Leaves for Brazil on State Visit -- LUSAKA, Zambia, November 15, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... infertility practice Carolina Conceptions welcomes new practice manager Nikki Duncan. ... team since the practice,s opening in 2006 and it is ... role of practice manager. Nikki is a graduate ... and previously served Carolina Conceptions as the Andrology Lab Manager. ...
Cached Biology Technology:Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 2Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 3Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 4Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 5Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 6Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 7Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 8Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 9President Banda Leaves for Brazil on State Visit 2President Banda Leaves for Brazil on State Visit 3President Banda Leaves for Brazil on State Visit 4President Banda Leaves for Brazil on State Visit 5President Banda Leaves for Brazil on State Visit 6President Banda Leaves for Brazil on State Visit 7President Banda Leaves for Brazil on State Visit 8
(Date:7/24/2014)... -- NXT-ID, Inc., (NXTD: OTCQB) a biometric authentication company focused on ... Wocket™, was recently the topic of  an interview on Boomer ... Pereira , CEO of NXT-ID, on July 9 th ... Gino Pereira explains how the Wocket will ... walks host Anita Finley through the step-by-step ...
(Date:7/23/2014)... , July 24, 2014 Pfenex Inc. (NYSE MKT: ... of 8,333,333 shares of its common stock at a price ... has granted the underwriters a 30-day option to purchase up ... public offering price. The shares are expected to begin trading ... symbol "PFNX". William Blair & Company, ...
(Date:7/23/2014)... early in life are at risk for developing ... new study, scientists have found that maltreatment affects ... for children,s long-term development. Previous studies focused on ... interacted with that child,s experiences in an effort ... new study, researchers were able to measure the ...
Breaking Biology News(10 mins):Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 2Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 3Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 4Pfenex Inc. Announces Pricing Of Initial Public Offering 2Stress tied to change in children's gene expression related to emotion regulation, physical health 2Stress tied to change in children's gene expression related to emotion regulation, physical health 3
... , This release is available in German . ... genes in the cells of their victim in order to ,reprogram, ... to live, making lots of new viruses instead. Luckily, ... is ensured by the cells, own sensors that recognise alien genetic ...
... and St. Andrews in the UK have found that the ... attractive they appear, and have found that diet may be ... be published in the December issue of Springer,s International ... a total of 54 Caucasian participants of both sexes were ...
... test to find undetected landmines. Students from the University ... when it comes into contact with chemicals leaked by buried ... solution that, when sprayed on to the ground, forms green ... say that the organism, which is cheap to produce, could ...
Cached Biology News:Study shows link between influenza virus and fever 2Skin color gives clues to health 2
... • Heat activated ,• Eliminates ... temperature ,• Excellent specificity allows extension ... secondary structures ,• Leaves an 'A' ... modified form of GeneChoice DNA Polymerase ...
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody...
... The Finnpipette BioControl ... innovative features as the ... universal handle fits allseven ... channel tip cone modules. ...
...
Biology Products: